Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Thompson

Showing results (21-30 of 200) with videos related to

Pageof 20
Sort By:
Journal of the Neurological Sciences|February 1, 2003
Interferon beta-1a in primary progressive multiple sclerosisSiobhan M Leary, Alan J Thompson
The Practitioner|June 15, 2007
GPs have pivotal role in managing MSThomas M Jenkins, Alan J Thompson
The Practitioner|October 31, 2009
Diagnosing and managing multiple sclerosisThomas M Jenkins, Alan J Thompson
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Advancing trial design in progressive multiple sclerosisDavid H Miller, Alan J Thompson
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2023
Managing patients with late-onset neutropenia during treatment with ocrelizumabSarah L Wright, Alan J Thompson
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2022
Two years of COVID-19 in the MS community: What have we learnt so far?Ana Zabalza, Alan J Thompson, Xavier Montalban
Journal of Neurology|September 17, 2004
Patient dissatisfaction: insights into the rehabilitation processClarence Liu, Alan J Thompson, E Diane Playford
Journal of Neurology|October 31, 2003
Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis?Clarence Liu, E Diane Playford, Alan J Thompson
The Lancet. Neurology|November 20, 2010
Pharmacological management of symptoms in multiple sclerosis: current approaches and future directionsAlan J Thompson, Ahmed T Toosy, Olga Ciccarelli
Journal of Rehabilitation Research and Development|June 8, 2002
Magnetic resonance imaging in primary progressive multiple sclerosisGordon T Ingle, Alan J Thompson, David H Miller
Pageof 20

Showing results (21-30 of 200) with videos related to

Sort By:
Pageof 20
Journal of the Neurological Sciences|February 1, 2003
Interferon beta-1a in primary progressive multiple sclerosisSiobhan M Leary, Alan J Thompson
The Practitioner|June 15, 2007
GPs have pivotal role in managing MSThomas M Jenkins, Alan J Thompson
The Practitioner|October 31, 2009
Diagnosing and managing multiple sclerosisThomas M Jenkins, Alan J Thompson
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Advancing trial design in progressive multiple sclerosisDavid H Miller, Alan J Thompson
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2023
Managing patients with late-onset neutropenia during treatment with ocrelizumabSarah L Wright, Alan J Thompson
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2022
Two years of COVID-19 in the MS community: What have we learnt so far?Ana Zabalza, Alan J Thompson, Xavier Montalban
Journal of Neurology|September 17, 2004
Patient dissatisfaction: insights into the rehabilitation processClarence Liu, Alan J Thompson, E Diane Playford
Journal of Neurology|October 31, 2003
Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis?Clarence Liu, E Diane Playford, Alan J Thompson
The Lancet. Neurology|November 20, 2010
Pharmacological management of symptoms in multiple sclerosis: current approaches and future directionsAlan J Thompson, Ahmed T Toosy, Olga Ciccarelli
Journal of Rehabilitation Research and Development|June 8, 2002
Magnetic resonance imaging in primary progressive multiple sclerosisGordon T Ingle, Alan J Thompson, David H Miller
Pageof 20